secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHEMED CORP (CHE)
CIK:        0000019584
Form:       8-K
Filed at:   2025-04-23T23:59:59+00:00
Accession:  0001562762-25-000088
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Chemed Q1 revenue up 9.8% to $646.9M; GAAP EPS $4.86, adjusted $5.63
--------------------------------------------------------------------

- VITAS net revenue +15.1% to $407.4M; ADC 22,244 (+13.1%); adjusted EBITDA $70.3M (+15.9%).
- Roto-Rooter revenue +1.8% to $239.5M but adjusted EBITDA -2.4% to $59.2M; margin down 108 bps.
- Cash $173.9M; no debt; repurchased 50k shares for $29.8M at $595.15/share.
- Covenant Health contributed ~$12M revenue, $2.6M EBITDA in Q1.
- Full-year guidance update deferred to Q2 earnings release in June.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/19584/000156276225000088/0001562762-25-000088-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/19584/000156276225000088/che-20250423x8k.htm
  HTML page:      https://secwatch.observer/filing/0001562762-25-000088

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer